Rachael Nokes
2021
In 2021, Rachael Nokes earned a total compensation of $719.7K as Senior Vice President of Finance at scPharmaceuticals, a 12% increase compared to previous year.
Compensation breakdown
| Bonus | $84,240 |
|---|---|
| Non-Equity Incentive Plan | $61,301 |
| Option Awards | $221,614 |
| Salary | $340,563 |
| Other | $11,987 |
| Total | $719,705 |
Nokes received $340.6K in salary, accounting for 47% of the total pay in 2021.
Nokes also received $84.2K in bonus, $61.3K in non-equity incentive plan, $221.6K in option awards and $12K in other compensation.
Rankings
In 2021, Rachael Nokes' compensation ranked 9,819th out of 12,415 executives tracked by ExecPay. In other words, Nokes earned more than 20.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,819 out of 12,415 | 21st |
Division Manufacturing | 4,347 out of 5,505 | 21st |
Major group Chemicals And Allied Products | 1,935 out of 2,375 | 19th |
Industry group Drugs | 1,718 out of 2,096 | 18th |
Industry Pharmaceutical Preparations | 1,278 out of 1,546 | 17th |
Source: SEC filing on April 28, 2022.
Nokes' colleagues
We found one more compensation record of an executive who worked with Rachael Nokes at scPharmaceuticals in 2021.
2021
John Tucker
scPharmaceuticals
Chief Executive Officer
News
scPharmaceuticals CEO John Tucker's 2022 pay slips 14% to $1.6M
April 27, 2023
scPharmaceuticals CEO John Tucker's 2021 pay rises 7% to $1.9M
April 28, 2022
scPharmaceuticals CEO John Tucker's 2020 pay jumps 40% to $1.7M
April 27, 2021
scPharmaceuticals CEO John Tucker's 2019 pay slips 17% to $1.2M
April 27, 2020